COVID-19系统综述的报告与方法学质量亟待提高:一项证据图谱研究
该研究采用证据图谱方法,系统检索截至2020年6月的COVID-19系统综述,使用AMSTAR 2和PRISMA清单评估其质量。共纳入243篇综述,结果显示方法学质量大多为极低(61.7%),报告质量中位PRISMA评分为14分,提示需改进。
要点
- COVID-19系统综述方法学质量堪忧,61.7%为极低质量。
- 研究主题多集中于预后、临床表现和治疗,预防和病因较少。
核心结论
- COVID-19系统综述的方法学和报告质量整体较差,亟需提升。
研究设计与样本
- 研究采用证据图谱方法,系统检索PubMed、Embase、Cochrane Library等9个数据库,检索时间从建库至2020年6月。
- 共纳入243篇COVID-19系统综述,使用AMSTAR 2和PRISMA清单评估质量。
主要发现
- 方法学质量:30篇(12.3%)为中等,63篇(25.9%)为低,150篇(61.7%)为极低。
- 报告质量:PRISMA评分中位数(四分位距)为14(10-18)。
- 超过50%(128篇,52.7%)的综述来自14个发展中国家,中国贡献最多(76篇,31.3%)。
- 研究主题分布:预后104篇(42.8%),临床表现69篇(28.4%),治疗65篇(26.7%),诊断43篇(17.7%),病因30篇(12.3%),预防25篇(10.3%),患病率24篇(9.9%)。
- 研究人群:一般COVID-19患者161篇(66.3%),儿童22篇(9.1%),孕妇18篇(7.4%)。
临床怎么用
- 临床科研人员在开展和发表系统综述时,应严格遵循AMSTAR 2和PRISMA清单以提高方法学和报告质量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To assess the reporting and methodological quality of COVID-19 systematic reviews, and to analyze trends and gaps in the quality, clinical topics, author countries, and populations of the reviews using an evidence mapping approach. STUDY DESIGN AND SETTING: A structured search for systematic reviews concerning COVID-19 was performed using PubMed, Embase, Cochrane Library, Campbell Library, Web of Science, CBM, WanFang Data, CNKI, and CQVIP from inception until June 2020. The quality of each review was assessed using the Assessment of Multiple Systematic Reviews 2 (AMSTAR 2) checklist and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) checklist. RESULTS: In total, 243 systematic reviews met the inclusion criteria, over 50% of which (128, 52.7%) were from 14 developing countries, with China contributing the most reviews (76, 31.3%). In terms of methodological quality of the studies, 30 (12.3%) were of moderate quality, 63 (25.9%) were of low quality, and 150 (61.7%) were of critically low quality. In terms of reporting quality, the median (interquartile range) PRISMA score was 14 (10-18). Regarding the topics of the reviews, 24 (9.9%) focused on the prevalence of COVID-19, 69 (28.4%) focused on the clinical manifestations, 30 (12.3%) focused on etiology, 43 (17.7%) focused on diagnosis, 65 (26.7%) focused on treatment, 104 (42.8%) focused on prognosis, and 25 (10.3%) focused on prevention. These studies mainly focused on general patients with COVID-19 (161, 66.3%), followed by children (22, 9.1%) and pregnant patients (18, 7.4%). CONCLUSION: This study systematically evaluated the methodological and reporting quality of systematic reviews of COVID-19, summarizing and analyzing trends in their clinical topics, author countries, and study populations.
引用
- Li Y, Cao L, Zhang Z, et al. Reporting and methodological quality of COVID-19 systematic reviews needs to be improved: an evidence mapping. J Clin Epidemiol. 2021. PMID: 33657455. doi:10.1016/j.jclinepi.2021.02.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。